Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.11. | Probiotix Health PLC - Result of Requisitioned General Meeting | 4 | RNS | ||
18.10. | OptiBiotix Health - Response to Publication of Circular by ProBiotix | 1 | RNS | ||
PROBIOTIX HEALTH Aktie jetzt für 0€ handeln | |||||
10.10. | Probiotix Health touts new deal with Mexico-based Raff for LPLDL | 3 | Alliance News | ||
10.10. | Probiotix Health PLC - New Commercial Partnership in Mexico | 1 | RNS | ||
09.10. | ProBiotix Health posts strong performance as US sales improve | 2 | Alliance News | ||
08.10. | Probiotix Health PLC - Q3 2024 Trading Update | 1 | RNS | ||
03.10. | Probiotix Health PLC - New Commercial Partnership in Ukraine | - | RNS | ||
26.09. | IN BRIEF: ProBiotix Health and shareholder OptiBiotix continue spat | 2 | Alliance News | ||
26.09. | OptiBiotix Health - Response to Probiotix Health requisition notice | 2 | RNS | ||
16.09. | Probiotix Health PLC - New Commercial Partnership in Greece | 1 | RNS | ||
06.09. | ProBiotix says fundraise valid after shareholder OptiBiotix hits out | 2 | Alliance News | ||
05.09. | OptiBiotix Health - ProBiotix Health plc Fundraise | 2 | RNS | ||
04.09. | Probiotix Health PLC - Share Subscription and Proposed Board Appointment | - | RNS | ||
30.08. | EARNINGS: ProBiotix Health hails positive outlook as revenue surges | 2 | Alliance News | ||
30.08. | Probiotix Health PLC - Half-year Report | - | RNS | ||
15.08. | IN BRIEF: ProBiotix Health enters sales agreement with DanCare Health | 2 | Alliance News | ||
15.08. | Probiotix Health PLC - New commercial partnership agreement in China | 1 | RNS | ||
08.08. | Probiotix Health PLC - Result of AGM | - | RNS | ||
29.07. | Probiotix Health PLC - New appointment | - | RNS | ||
15.07. | Probiotix Health PLC - Six month trading update | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BRAIN BIOTECH | 3,100 | -2,82 % | Brain Biotech, DAX, Erste Group, Fielmann, Microsoft, TUI - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
MUSTGROW BIOLOGICS | 1,215 | -0,41 % | MustGrow Biologics Corp.: MustGrow Provides 2024 Pipeline Update | MustGrow transitions from R&D to commercialization.TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026.Commercialization of... ► Artikel lesen | |
OPTIBIOTIX HEALTH | 0,150 | +0,67 % | OptiBiotix Health - Requisition update | ||
ADMA BIOLOGICS | 21,370 | 0,00 % | Adma Biologics Aktie: Erholung nach starkem Kursrückgang | ||
RECURSION PHARMACEUTICALS | 6,040 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
EVOTEC | 9,890 | -0,15 % | KURSEXPLOSION bei Biotech-Aktie! BioNTech, Evotec, Nyxoah | Geht es bei Evotec jetzt doch ganz schnell? Ein Finanzinvestor positioniert sich jedenfalls für eine Übernahme und die Aktie schoss zuletzt kräftig nach oben. Ist damit die Enttäuschung über die Quartalszahlen... ► Artikel lesen | |
QUANTUM-SI | 1,400 | 0,00 % | Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis | ||
QIAGEN | 39,665 | +2,12 % | Neue 6,00% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC7RDU1/ WKN VC7RDU) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
89BIO | 7,980 | 0,00 % | 89bio, Inc.: 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024 | SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for... ► Artikel lesen | |
LONGBOARD PHARMACEUTICALS | 59,76 | 0,00 % | Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological... ► Artikel lesen | |
RELAY THERAPEUTICS | 4,660 | 0,00 % | Aktie von Relay Therapeutics erreicht 52-Wochen-Tief bei 5,59 US-Dollar | ||
STRUCTURE THERAPEUTICS | 32,710 | 0,00 % | Structure Therapeutics reports Q3 results | ||
SPRINGWORKS THERAPEUTICS | 37,440 | 0,00 % | SpringWorks started at outperform by Evercore ahead of FDA decision | ||
4D MOLECULAR THERAPEUTICS | 8,410 | 0,00 % | Analyst Expectations For 4D Molecular Therapeutics' Future | ||
DYNE THERAPEUTICS | 30,000 | 0,00 % | Dyne Therapeutics: Leitender Vizepräsident veräußert Aktien im Wert von 77.127 US-Dollar |